We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.18%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$325B
AUM Growth
-$10.8B
(-3.2%)
Cap. Flow
-$13.4B
Cap. Flow
% of AUM
-4.12%
Top 10 Holdings %
Top 10 Hldgs %
22.35%
Holding
3,492
New
145
Increased
887
Reduced
2,282
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$899M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$895M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$597M |
| 4 |
Clarivate
CLVT
|
+$315M |
| 5 |
Mastercard
MA
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.03B |
| 2 |
Apple
AAPL
|
+$962M |
| 3 |
Intel
INTC
|
+$470M |
| 4 |
Microsoft
MSFT
|
+$449M |
| 5 |
Home Depot
HD
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.56% |
| 2 | Financials | 13.11% |
| 3 | Healthcare | 12.33% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Aligos Therapeutics
ALGS
$34.9M
| $1.37M | ﹤0.01% |
3,529
+960
| +37% | +$380K |
|
2827
Spero Therapeutics
SPRO
$73M
| $1.36M | ﹤0.01% |
71,121
+7,079
| +11% | +$114K |
|
2828
Rush Enterprises Class B
RUSHB
$6.14B
| $1.36M | ﹤0.01% |
45,323
+68
| +0.2% | +$1.92K |
|
|
ICVX
2829
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $1.36M | ﹤0.01% |
+45,921
| New | +$1.56M |
|
|
MRNS
2830
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.36M | ﹤0.01% |
119,323
-9,133
| -7% | -$126K |
|
|
CNBKA
2831
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $1.36M | ﹤0.01% |
11,873
+32
| +0.3% | +$3.66K |
|
2832
Forte Biosciences
FBRX
$1.57B
| $1.35M | ﹤0.01% |
1,894
+144
| +8% | +$79.8K |
|
2833
Willdan Group
WLDN
$1.3B
| $1.35M | ﹤0.01% |
38,570
+1,484
| +4% | +$55.9K |
|
2834
Lifecore Biomedical
LFCR
$190M
| $1.35M | ﹤0.01% |
146,378
-22,601
| -13% | -$246K |
|
|
PARAA
2835
DELISTED
Paramount Global Class A
PARAA
| $1.35M | ﹤0.01% |
32,041
-1,346
| -4% | -$60.2K |
|
2836
Aemetis
AMTX
$124M
| $1.34M | ﹤0.01% |
91,347
+4,834
| +6% | +$53.4K |
|
2837
Spyre Therapeutics
SYRE
$9.25B
| $1.34M | ﹤0.01% |
7,186
-185
| -3% | -$32.4K |
|
|
AKTS
2838
DELISTED
Akoustis Technologies Inc
AKTS
| $1.34M | ﹤0.01% |
135,543
+3,643
| +3% | +$34.9K |
|
2839
Southern First Bancshares
SFST
$600M
| $1.34M | ﹤0.01% |
26,918
-93
| -0.3% | -$4.7K |
|
2840
Full House Resorts
FLL
$89M
| $1.33M | ﹤0.01% |
154,650
+11,205
| +8% | +$95.6K |
|
2841
AXT Inc
AXTI
$5.8B
| $1.33M | ﹤0.01% |
167,872
+3,303
| +2% | +$30.8K |
|
|
BNR
2842
Burning Rock Biotech
BNR
$92.9M
| $1.33M | ﹤0.01% |
7,440
+500
| +7% | +$111K |
|
2843
Rafael Holdings
RFL
$107M
| $1.33M | ﹤0.01% |
36,504
-1,051
| -3% | -$48.2K |
|
2844
908 Devices
MASS
$364M
| $1.32M | ﹤0.01% |
36,922
+19,508
| +112% | +$663K |
|
|
VIRX
2845
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $1.32M | ﹤0.01% |
151,458
+3,724
| +3% | +$36.7K |
|
2846
W&T Offshore
WTI
$518M
| $1.32M | ﹤0.01% |
399,215
-12,066
| -3% | -$43.1K |
|
|
RRD
2847
DELISTED
RR Donnelley & Sons Co.
RRD
| $1.31M | ﹤0.01% |
300,351
-603
| -0.2% | -$3.22K |
|
2848
Seneca Foods Class A
SENEA
$1.21B
| $1.31M | ﹤0.01% |
27,517
-3,895
| -12% | -$197K |
|
2849
SoundThinking
SSTI
$103M
| $1.31M | ﹤0.01% |
36,046
+6,943
| +24% | +$291K |
|
2850
Southern Missouri Bancorp
SMBC
$850M
| $1.31M | ﹤0.01% |
31,111
-1,502
| -5% | -$67.2K |
|
Similar funds
VFT
Nuveen's Q3 2021 Portfolio in Review
As of Q3 2021, Nuveen held 3,492 positions worth $325B, down 3.2% from $335B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nuveen withdrew a net $13.4B in Q3 2021, closing 80 positions and reducing 2,282 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $219M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Nuveen opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $596M.
- Nuveen's largest Q3 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 6,810,000 shares worth $596M.
- Nuveen added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2021, an estimated $899M increase.
- Nuveen's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $1.03B.
- Nuveen fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $219M.
- Nuveen's ten largest holdings make up 22% of its $325B portfolio in Q3 2021.
- Nuveen opened 145 new positions and closed 80 in Q3 2021.
- Nuveen's portfolio value fell 3.2% quarter-over-quarter to $325B.
Based on Nuveen's 13F filing for Q3 2021, filed 12 Nov 2021.